Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2006-07-04
2006-07-04
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C530S350000
Reexamination Certificate
active
07070784
ABSTRACT:
Disclosed are novel methods for increasing muscle mass by means of immunization against Growth Differentiation Factor 8 (GDF-8, myostatin). Immunization is preferably effected by administration of analogues of GDF-8 which are capable of inducing antibody production against homologous GDF-8. Especially preferred as an immunogen is homologous GDF-8 which has been modified by introduction of one single or a few foreign, immunodominant and promiscuous T-cell epitopes while substantially preserving the tertiary structure of the homologous GDF-8. Also disclosed are nucleic acid vaccination against GDF-8 and vaccination using live vaccines as well as methods and means useful for the vaccination. Such methods and means include methods for identification of useful immunogenic GDF-8 analogues, methods for the preparation of analogues and pharmaceutical formulations, as well as nucleic acid fragments, vectors, transformed cells, polypeptides and pharmaceutical formulations.
REFERENCES:
patent: 6369201 (2002-04-01), Barker et al.
patent: 6607884 (2003-08-01), Lee et al.
patent: 2333706 (1999-08-01), None
patent: WO 95/05849 (1995-03-01), None
patent: WO 95/07707 (1995-03-01), None
patent: WO 98/23635 (1998-06-01), None
patent: WO 98/46642 (1998-10-01), None
patent: WO 99/02667 (1999-01-01), None
patent: WO 99/42573 (1999-08-01), None
Wearsch, Pamela et al.; “Structural Transitions..” Biochemistry, vol. 37, No. 16, 1998.
Southwood, Scott et al.; “Several Common..” Journal of Immunology 1998, pp. 3363-3373.
Donnelly, John et al.;“DNA Vaccines” Annu. Rev. Immunol. 1997 15:617-48.
Donnelly, John J. et al.;“Minireview of DNA Vaccines” Life Sciences, vol. 60, No. 3, pp. 163-172.
McPherron, Alexandra C. et al.;“Regulation of ..” Nature vol. 387 May 1997.
McPherron, Alexandra C. et al.;“Double muscling in ..” Proc. Natl. Acad. Sci. USA vol. 94, pp. 12457-12461, Nov. 1997.
Barr, Ian G. eta l.;“ISCOMS..” Immunol. and Cell Biology (1996) 74, 8-25.
Dalum, Iben et al.;“Breaking of B Cell..” Journal of Immunol. 1996 pp. 4796-4804.
Dempsey, Paul W. et al.;“C3d of Complement..” Science vol. 271, Jan. 19, 1996.
Morein, Bror et al.;“Immunostimulating..” Clin. Immunother, 3 (6): 461-475, 1995.
Alexander, Jeff et al.;“Development of High..” Immunity vol. 1, 751-761, Dec., 1994.
Falk, Kristen et al.;“Pool sequencing..” Immunogenetics 39: 230-242, 1994.
Hammer, Juergen et al.;“Promiscuous and ..” Cell, vol., 74, 197-203, Jul. 16, 1993.
Chicz, Roman M. et al.; J. Exp. Med. vol. 178, Jul. 1993 27-47.
P. D. Walker; “Bacterial vaccines:..” Vaccine, vol. 10, Issue 14, 1992.
Sinigaglia, F. et al.; “A malaria T-cell..” Nature vol. 336 22/29 Dec. 1988.
Gosselin, Edmund J. et al.;“Enhanced antigen..” J. of Immunol. vol. 140, 3477-3481 No. 11, Dec. 1992.
Meng et al. “Myostatin Regulates Skeletal Muscle Cell Differentiation in Chicken Primary Myoblast Cells” PNAS, vol. 94, 1997, pp. 12457-12461.
Lederman et al., “A Single Amino Acid Substitution in a Common Afriacan Allel of the CD4 Molecule Ablates Binding of the Monoclonal Antibody OKT4”, Molecular Immunology, vol. 28, No. 11, 1991, pp. 1171-1181.
Colman et al., “Effects of amino acid sequence changes on antibody-antigen interactions”, Research in Immunology, vol. 145, No. 1, 1994, pp. 33-36.
Abaza et al., “Effects of Amino acid Substitutions Outside an Antigenic. .” Journal of Protein Chemistry, vol. 11, No. 5, 1992, pp. 433-444.
Van Regenmortel et al., “Mapping Epitope Structure and Activity: From One-Dimensional Prediction to Four-Dimensional Description of Antigenic Specificity” Methods: A Companion to Methods in Enzymology, vol. 9, 1996, pp. 465-472.
Halkier Torben
Klysner Steen
Mouritsen Søren
Belyavskyi Michail
Chan Christina
Pharmexa A/S
LandOfFree
Method for down-regulating GDF-8 activity using immunogenic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for down-regulating GDF-8 activity using immunogenic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for down-regulating GDF-8 activity using immunogenic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3568885